glycosylation Archives

SARS-COV-2’s Defences Against Detection.

18 May 2021

What Variants Want. Considerable coverage is being given to variant B1.617. This is the ‘Indian’ variant if you use the incorrect basis of giving single country, geographical names to variants that appear globally across multiple variants and are not new, having been in existence for months and in some cases, over a year. As part […]

Questions For Those Offering You A ‘Vaccine’.

4 May 2021

Beware ‘Excited’ Non-Healthcare Workers. As another cohort is now to be offered the antivirals (they are not vaccines), it is apposite to set out some questions to ask those who are falling over themselves to vaccinate you. There is an irony in the fact that reception staff at GPs’ surgeries who are usually obdurate and […]

These ‘Vaccines’ Become More Dangerous By The Day.

15 April 2021

Treatments Targeting The S Protein Were Already Ineffective. We have been vehement critics of the miracle ‘wonderdrug’ antivirals (they are not vaccines) rushed onto the market in recent months. In October 2020, we first set out the difference between vaccines and antivirals and highlighted the risks in RNA/mRNA vaccine candidates: these fall into the category […]

IgA – Faster, Stronger and More Effective.

11 March 2021

The Star Player On Your Team. Following seroconversion, immumoglobulin A (IgA) istoype is the most frequently created antibody in the immune system. This is principally because it dominates the upper respiratory tract, which is usually the first point of contact between pathogen and human. Therefore, it is needed more frequently than the other isotypes. As […]

Why Geographical Naming Of Variants Is Wrong.

5 March 2021

B1.1.28 and B1.351 – They Are All ‘Johnny Foreigner’ Variants To The Government. In recent months, the government has made much of the emergence of new ‘killer mutations of death’, obsessing about ‘South African’ and ‘Brazilian’ geographical variants. Before going further, one should refer to these variants by their correct designations: the Brazilian variant is […]

More Infectious Equals More Vulnerable.

28 January 2021

Infectiousness And Infectivity Are Not The Same. Infectiousness is how easily a pathogen can spread and infectivity is the level of disease severity it can cause. We explained this in more detail earlier this month in response to the UK government’s regular – and one would predicate deliberate – confusion of the two. S-VoC / […]

Nitric Oxide Immunity In The Upper Respiratory Tract.

24 January 2021

The Upper Respiratory Tract Is The Key Battleground. Back in July 2020, we first explained the crucial significance of vitamin D as an effective viral countermeasure as well as the significance of vitamin D deficiency in SARS-CoV-2’s pathogenesis and COVID-19 disease severity. Then in October we highlighted the importance of the vitamin D→endothelial nitric oxide synthase→nitric […]

WHO Shows PCR Testing Gets It Wrong.

21 January 2021

What Is Nucleic Acid Testing? Nucleic acid testing, more commonly known as PCR or RT-PCR testing, is one of the three main types of viral testing. There is a full explanation of these three types here but concentrating on PCR testing, it tests a sample for tiny fragments of viral RNA. It shows only the […]

Antibody-Dependent Enhancement And This Rushed ‘Vaccine’.

19 January 2021

What is Antibody-Dependent Enhancement? As we have set out previously, it takes 10-15 years to develop a vaccine. This timescale is entirely understandable and justifiable when you consider that the vaccine has to be both effective and safe. Safe includes not causing unacceptable side effects, which include the vaccine or immune system’s response triggering autoimmunity, […]

Exoribonuclease – Your Starter For Ten Mr Prime Minister.

30 December 2020

Q1. How can a virus containing an exoribonuclease mutate in the way you are saying? Coronaviruses possess an exoribonuclease within nonstructural protein 14 (nsp14-ExoN). This functions as a proofreader during viral transcription and encoding, ensuring high fidelity replication. This minimises the potential for mutation, as shown by the fact that sarbecovirus/lineage B betacoronaviruses with their […]